|
1
|
Hansson GK and Hermansson A: The immune
system in atherosclerosis. Nat Immunol. 12:204–212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan H, Wang S, Li Z, Zhao W, Wang Z, Sun
Z, Pan Y and Zhu J: Upregulation of miRNA-155 expression by OxLDL
in dendritic cells involves JAK1/2 kinase and transcription factors
YY1 and MYB. Int J Mol Med. 37:1371–1378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moore KJ and Tabas I: Macrophages in the
pathogenesis of atherosclerosis. Cell. 145:341–355. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bailey CJ and Turner RC: Metformin. N Engl
J Med. 334:574–579. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hundal RS, Krssak M, Dufour S, Laurent D,
Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF,
Landau BR and Shulman GI: Mechanism by which metformin reduces
glucose production in type 2 diabetes. Diabetes. 49:2063–2069.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hundal RS and Inzucchi SE: Metformin-New
understandings, new uses. Drugs. 63:1879–1894. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fitch K, Abbara S, Lee H, Stavrou E, Sacks
R, Michel T, Hemphill L, Torriani M and Grinspoon S: Effects of
lifestyle modification and metformin on atherosclerotic indices
among HIV-infected patients with the metabolic syndrome. AIDS.
26:587–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song J, Ren PP, Zhang L, Wang XL, Chen L
and Shen YH: Metformin reduces lipid accumulation in macrophages by
inhibiting FOXO1-mediated transcription of fatty acid-binding
protein 4. Biochem Biophys Res Commun. 393:89–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koren-Gluzer M, Aviram M and Hayek T:
Metformin inhibits macrophage cholesterol biosynthesis rate:
Possible role for metformin-induced oxidative stress. Biochem
Biophys Res Commun. 439:396–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Daigneault M, Preston JA, Marriott HM,
Whyte MK and Dockrell DH: The identification of markers of
macrophage differentiation in PMA-stimulated THP-1 cells and
monocyte-derived macrophages. PLoS One. 5:e86682010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Q, Ji J, Hao S, Zhang M, Li K and
Qiao T: Iron together with lipid downregulates protein levels of
ceruloplasmin in macrophages associated with rapid foam cell
formation. J Atheroscler Thromb. 23:1201–1211. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan H, Li Y, Peng X, Huang D, Gui L and
Huang B: Resistance of mitochondrial DNA-depleted cells against
oxidized low-density lipoprotein-induced macrophage pyroptosis. Mol
Med Rep. 13:4393–4399. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goeritzer M, Schlager S, Radovic B,
Madreiter CT, Rainer S, Thomas G, Lord CC, Sacks J, Brown AL, Vujic
N, et al: Deletion of CGI-58 or adipose triglyceride lipase
differently affects macrophage function and atherosclerosis. J
Lipid Res. 55:2562–2575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aflaki E, Doddapattar P, Radović B,
Povoden S, Kolb D, Vujić N, Wegscheider M, Koefeler H, Hornemann T,
Graier WF, et al: C16 ceramide is crucial for
triacylglycerol-induced apoptosis in macrophages. Cell Death Dis.
3:e2802012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seimon TA, Nadolski MJ, Liao X, Magallon
J, Nguyen M, Feric NT, Koschinsky ML, Harkewicz R, Witztum JL,
Tsimikas S, et al: Atherogenic lipids and lipoproteins trigger
CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic
reticulum stress. Cell Metab. 12:467–482. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cnop M, Igoillo-Esteve M, Cunha DA,
Ladrière L and Eizirik DL: An update on lipotoxic endoplasmic
reticulum stress in pancreatic beta-cells. Biochem Soc Trans.
36:909–915. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ron D and Walter P: Signal integration in
the endoplasmic reticulum unfolded protein response. Nat Rev Mol
Cell Biol. 8:519–529. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yao S, Zong C, Zhang Y, Sang H, Yang M,
Jiao P, Fang Y, Yang N, Song G and Qin S: Activating transcription
factor 6 mediates oxidized LDL-induced cholesterol accumulation and
apoptosis in macrophages by up-regulating CHOP expression. J
Atheroscler Thromb. 20:94–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sekiya M, Yamamuro D, Ohshiro T, Honda A,
Takahashi M, Kumagai M, Sakai K, Nagashima S, Tomoda H, Igarashi M,
et al: Absence of Nceh1 augments 25-hydroxycholesterol-induced ER
stress and apoptosis in macrophages. J Lipid Res. 55:2082–2092.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song J, Ren P, Zhang L, Wang XL, Chen L
and Shen YH: Metformin reduces lipid accumulation in macrophages by
inhibiting FOXO1-mediated transcription of fatty acid-binding
protein 4. Biochem Biophys Res Commun. 393:89–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murphy JE, Tedbury PR, Homer-Vanniasinkam
S, Walker JH and Ponnambalam S: Biochemistry and cell biology of
mammalian scavenger receptors. Atherosclerosis. 182:1–15. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan H, Wang S, Li Z, Sun Z, Zan J, Zhao W,
Pan Y, Wang Z, Wu M and Zhu J: Rspo2 suppresses CD36-mediated
apoptosis in oxidized low density lipoprotein-induced macrophages.
Mol Med Rep. 14:2945–2952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang S, Sun Z, Zhang X, Li Z, Wu M, Zhao
W, Wang H, Chen T, Yan H and Zhu J: Wnt1 positively regulates CD36
expression via TCF4 and PPAR-γ in macrophages. Cell Physiol
Biochem. 35:1289–1302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao W, Sun Z, Wang S, Li Z and Zheng L:
Wnt1 participates in inflammation induced by lipopolysaccharide
through upregulating scavenger receptor A and NF-kB. Inflammation.
38:1700–1706. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mietus-Snyder M, Glass CK and Pitas RE:
Transcriptional activation of scavenger receptor expression in
human smooth muscle cells requires AP-1/c-Jun and C/EBPbeta: Both
AP-1 binding and JNK activation are induced by phorbol esters and
oxidative stress. Arterioscler Thromb Vasc Biol. 18:1440–1449.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gillessen S, Gilson C, James N, Adler A,
Sydes MR and Clarke N; STAMPEDE Trial Management Group, :
Repurposing metformin as therapy for prostate cancer within the
STAMPEDE trial platform. Eur Urol. 70:906–908. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cameron AR, Morrison VL, Levin D, Mohan M,
Forteath C, Beall C, McNeilly AD, Balfour DJ, Savinko T, Wong AK,
et al: Anti-inflammatory effects of metformin irrespective of
diabetes status. Circ Res. 119:652–665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ramakrishna G, Sen B, Trehanpati N and
Sarin SK: Repurposing of metformin in liver injury: The JNK
conundrum. J Hepatol. 64:749–750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gerstein HC, Miller ME, Ismail-Beigi F,
Largay J, McDonald C, Lochnan HA and Booth GL; ACCORD Study Group,
: Effects of intensive glycaemic control on ischaemic heart
disease: Analysis of data from the randomised, controlled ACCORD
trial. Lancet. 384:1936–1941. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
ACCORD Study Group, . Nine-year effects of
3.7 years of intensive glycemic control on cardiovascular outcomes.
Diabetes Care. 39:701–708. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Q, Zhang M, Torres G, Wu S, Ouyang C,
Xie Z and Zou MH: Metformin suppresses diabetes-accelerated
atherosclerosis via the inhibition of Drp1-mediated mitochondrial
fission. Diabetes. 66:193–205. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu W, Deng YY, Yang L, Zhao S, Liu J, Zhao
Z, Wang L, Maharjan P, Gao S, Tian Y, et al: Metformin ameliorates
the proinflammatory state in patients with carotid artery
atherosclerosis through sirtuin 1 induction. Transl Res.
166:451–458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koren-Gluzer M, Aviram M and Hayek T:
Metformin inhibits macrophage cholesterol biosynthesis rate:
Possible role for metformin-induced oxidative stress. Biochem
Biophys Res Commun. 439:396–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vasamsetti SB, Karnewar S, Kanugula AK,
Thatipalli AR, Kumar JM and Kotamraju S: Metformin inhibits
monocyte-to-macrophage differentiation via AMPK-mediated inhibition
of STAT3 activation: Potential role in atherosclerosis. Diabetes.
64:2028–2041. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu X, Mei T, Chen W and Ye S: Comparison
of antidiabetic medications during the treatment ofatherosclerosis
in T2DM patients. Mediators Inflamm. 2017:50327082017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luo F, Guo Y, Ruan GY, Long JK, Zheng XL,
Xia Q, Zhao SP, Peng DQ, Fang ZF and Li XP: Combined use of
metformin and atorvastatin attenuates atherosclerosis in rabbits
fed a high-cholesterol diet. Sci Rep. 7:21692017. View Article : Google Scholar : PubMed/NCBI
|
